Bio-Rad Laboratories Inc (BIO) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.

Total Revenue Chart for Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc (BIO) revenue for FY2025 was USD 2.6B, a 0.7% change from FY2024. Bio-Rad Laboratories Inc's revenue grew from USD 102.3M in 1985 to USD 2.6B in 2025 (2425.1% over 40 years). Earnings per share grew from USD 1.29 in 2000 to USD 27.85 in 2025 (2051.3%). Revenue compound annual growth rate: 5-year CAGR of 0.3%, 10-year CAGR of 2.5%, 20-year CAGR of 4.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.